News & Alerts
-
Oct- 2023 -24 October
Upcoming Event: 1st Academic Conference of Safety Psychology and Behavior for Healthcare
The International Association of Risk Management in Medicine (IARMM) has announced the Joint Conference for Clinical Safety Promotion, featuring the…
Read More » -
24 October
Hamilton Field Services Forge Expert Partnerships in Pharma and Life Sciences Industries
RENO, Nev., Oct. 24, 2023 – Hamilton, the globally recognized leader in automation technology and analytical sensors, has unveiled a…
Read More » -
24 October
Study Reveals 72% of Consumers Concerned About Health Data Misuse, as Lack of Informed Consent Tops Data Privacy Worries
WARRINGTON, England, Oct. 24, 2023. A recent research report released by Cassie, a globally recognized consent management platform serving Fortune…
Read More » -
23 October
Innovative Anti-Tumor Drug, LX-039, Shows Promise in Phase I Clinical Study Data Presented at ESMO 2023
SHANGHAI, Oct. 23, 2023 — Luoxin Pharmaceutical Group Stock Co., Ltd. (Luoxin Pharmaceutical) has made a significant stride in the…
Read More » -
23 October
Sumitomo Pharma’s ORGOVYX Receives Health Canada Approval for Advanced Prostate Cancer Treatment
MISSISSAUGA, Ontario, Oct. 23, 202— In a significant development in the field of advanced prostate cancer treatment, Sumitomo Pharma Canada,…
Read More » -
23 October
INVO Bioscience and NAYA Biosciences Announce Merger for Breakthrough Fertility and Oncology Treatments
SARASOTA, Fla. and AVENTURA, Fla., Oct. 23, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) and NAYA Biosciences Inc. have jointly…
Read More » -
19 October
Commonly Used Drug Amitriptyline Might Be New Treatment Option for IBS
By Cara Murez HealthDay Reporter An inexpensive medication long used for depression and migraines now has a clinical trial to…
Read More » -
19 October
FDA Grants Approval to UCB’s Bimzelx (bimekizumab-bkzx) for Moderate to Severe Plaque Psoriasis Treatment
UCB, a global biopharmaceutical company, has announced the approval of Bimzelx® (bimekizumab-bkzx) by the U.S. Food and Drug Administration (FDA)…
Read More » -
19 October
Sterile Dosage Form Market Anticipated to Reach US$ 1.1 Billion by 2033, Driven by Rising Demand for Infection-Free Medical Products | Future Market Insights, Inc.
The sterile dosage forms market will be valued at US$ 582.9 million in 2023. The market is anticipated to grow at a 6.7% CAGR throughout the…
Read More » -
19 October
Cholangiocarcinoma Market Growth Projection 2019 to 2032 By DelveInsight
DelveInsight, a leading market intelligence and analytics firm, has unveiled its comprehensive report on the Cholangiocarcinoma market. This report provides…
Read More »
